Explain this page
Arphra AIPlain-English read on Moderna, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
- RVMDRevolution Medicines, Inc.$139.48$29.65B
- BBIOBridgeBio Pharma, Inc.$68.56$13.29B
- JAZZJazz Pharmaceuticals plc$202.72$12.72B
- MDGLMadrigal Pharmaceuticals, Inc.$513.72$11.78B
- EXELExelixis, Inc.$43.68$11.1B
- BMRNBioMarin Pharmaceutical Inc.$54.06$10.4B
- TECHBio-Techne Corporation$55.02$8.61B
- HALOHalozyme Therapeutics, Inc.$63.96$7.58B
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.39% | -2.04% | +1.52% | -14.02% | +90.65% | +56.19% | +70.28% | -64.16% | -75.06% | +147.63% | +147.63% |
Aftermarket
LiveLast trade
$46.02
8 sh
Bid
$45.91
14 sh
Ask
$46.10
40 sh
Spread
$0.190
Sector & industry today
LiveSectors
- Technology+3.35%
- Basic Materials+0.94%
- Energy+0.84%
- Consumer Cyclical+0.48%
- Industrials+0.26%
- Communication Services+0.16%
- Financial Services-0.80%
- Healthcare-0.83%
- Consumer Defensive-0.84%
- Utilities-1.17%
- Real Estate-1.32%
Top industries (issuer's industry highlighted)
- Biotechnology-2.47%
- Computer Hardware+8.82%
- Software - Infrastructure+8.14%
- Coal+5.93%
- Broadcasting+5.36%
- Consulting Services+4.97%
- Manufacturing - Metal Fabrication+4.57%
- Staffing & Employment Services+4.49%
- Integrated Freight & Logistics+4.19%
- Gambling, Resorts & Casinos+3.99%
- Software - Application+3.94%
- Medical - Equipment & Services+3.52%
Fair value
Football field →Weighted blend
$11.90
-74.16% vs spot
Recommendation
Sell
5 of 5 methods
Method spread
0bull5bear
±5% threshold
Analyst PT consensus: $37.30 (-19.02%)
Total assets
$12.34B
Total debt
$1.92B
Cash & equiv
$2.6B
Operating CF
-$1.87B
Free cash flow
-$2.07B
Buybacks
$0
Analyst view
DB · price_targets + analyst_gradesConsensus target
$37.30
-19.02% upside
Low
$17.00
Median
$35.50
High
$63.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Moderna Recognized by TIME as One of the World's Most Impactful Companiesaccessnewswire.com·May 12, 2026
- Moderna Recognized by TIME as One of the World's Most Impactful Companiesaccessnewswire.com·May 12, 2026
- Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Moderna's AI Could Get a Hantavirus Vaccine Here Fasterpymnts.com·May 12, 2026
- Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010accessnewswire.com·May 06, 2026
- Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challengesgurufocus.com·May 02, 2026
- Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcriptseekingalpha.com·May 01, 2026
- Moderna Reports Q1 Loss, Stock Jumps on Strong International Saleszacks.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $389M | -$1.34B | $-3.40 |
| Q4 Dec 2025 | $678M | -$826M | $-2.11 |
| Q3 Sep 2025 | $1.02B | -$200M | $-0.51 |
| Q2 Jun 2025 | $142M | -$825M | $-2.13 |
| Q1 Mar 2025 | $107M | -$971M | $-2.52 |
| Q4 Dec 2024 | $956M | -$1.12B | $-2.91 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Hussain Abbas director | Sell | 5,682 | $264.95K | May 01, 2026 |
Klinger Shannon Thyme officer: Chief Legal Officer | Sell | 13,885 | $726.05K | Mar 02, 2026 |
Hoge Stephen officer: President | Sell | 160,009 | $7.81M | Feb 23, 2026 |
AFEYAN NOUBAR director | Sell | 23,853 | $703.31K | Dec 11, 2025 |
Hussain Abbas director | Sell | 504 | $13.91K | Dec 09, 2025 |
Hussain Abbas director | Sell | 312 | $8.74K | Jun 11, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $1.94B | -$3.07B | -$2.82B | $-7.26 | -145.16% |
| FY 2024 | $3.2B | -$3.95B | -$3.56B | $-9.27 | -111.32% |
| FY 2023 | $6.85B | -$4.24B | -$4.71B | $-12.34 | -68.84% |
| FY 2022 | $18.88B | $9.42B | $8.36B | $20.10 | +44.30% |
| FY 2021 | $17.74B | $13.3B | $12.2B | $28.29 | +68.80% |